References
Sun H, Bai J, Chen F, Jin Y, Yu Y, Jin L, Fu S (2010) RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects. Breast Cancer Res Treat [Epub ahead of print]
Zhou GW, Hu J, Peng XD, Li Q (2010) RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat [Epub ahead of print]
Gao LB, Pan XM, Li LJ, Liang WB, Zhu Y, Zhang LS, Wei YG, Tang M, Zhang L (2010) RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat [Epub ahead of print]
Hu R, Wei Y, Jiang WJ, Yao WX, Long QM, Zhang JH, Liang Y, Tang XL (2008) Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers. Sichuan Da Xue Xue Bao Yi Xue Ban 39:973–975
Lee KM, Choi JY, Kang C, Kang CP, Park SK, Cho H, Cho DY, Yoo KY, Noh DY, Ahn SH et al (2005) Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 11:4620–4626
Chang TW, Wang SM, Guo YL, Tsai PC, Huang CJ, Huang W (2006) Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan. Breast 15:754–761
Yu KD, Yang C, Fan L, Chen AX, Shao ZM (2010) RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies. Breast Cancer Res Treat [Epub ahead of print]
Wang Z, Dong H, Fu Y, Ding H (2010) RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects. Breast Cancer Res Treat [Epub ahead of print]
Acknowledgments
The authors are fully responsible for all the content and editorial decisions.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Pei-Hua Lu and Chen Li contributed equally to this work and should be considered as co-first authors.
Rights and permissions
About this article
Cite this article
Lu, PH., Li, C., Zhou, HY. et al. Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk. Breast Cancer Res Treat 125, 299–300 (2011). https://doi.org/10.1007/s10549-010-1189-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-1189-0